5212
F. Couty et al. / Tetrahedron Letters 44 (2003) 5209–5212
tal work will be needed, we therefore think that this
ring expansion occurs through a concerted pathway.
J.; Dumas, C.; Gomez Pardo, D. Bioorg. Med. Chem.
Lett. 1997, 7, 1343–1344.
5. (a) Wasserman, H. H.; Robinson, R. P.; Matsuyama, H.
Tetrahedron Lett. 1980, 21, 3493–3497; (b) Lednicer, D.;
Hauser, C. R. J. Am. Chem. Soc. 1957, 79, 4449–4451; (c)
Manhas, M. S.; Amin, S. G.; Bose, A. K. Heterocycles
1976, 5, 669–673.
6. Fugami, K.; Miura, K.; Morizawa, Y.; Oshima, K.;
Utimoto, K.; Nozaki, H. Tetrahedron 1989, 45, 3089–
3098.
7. Alcaide, B.; Almendros, P.; Aragoncillo, C.; Salgado, N.
R. J. Org. Chem. 1999, 64, 9596–9604. See also references
cited therein for other 4 to 5 ring enlargements.
8. Ungureanu, I.; Klotz, P.; Schoenfelder, A.; Mann, A. J.
Chem. Commun. 2001, 958–959.
In conclusion, we have described in this letter a
straightforward access to enantiopure 2-halomethyl or
2-methanesulfonyloxymethyl azetidines and 3-chloro14
or 3-methanesulfonyloxy pyrrolidines, and we have
examined the scope of the rearrangement of the former
four- into five-membered rings. Further functionalisa-
tion of these heterocycles is under active investigation
in our group.
Acknowledgements
9. (a) Agami, C.; Couty, F.; Rabasso, N. Tetrahedron Lett.
2002, 43, 4633–4636; (b) Carlin-Sinclair, A.; Couty, F.;
Rabasso, N. Synlett 2003, 726–729.
10. Outurquin, F.; Pannecoucke, X.; Berthe, B.; Paulmier, C.
Eur. J. Org. Chem. 2002, 1007–1014.
CNRS is acknowledged for generous financial support
(Soutien jeune e´quipe). The authors wish to thank Drs.
C. Robert-Labarre and M. J. Pouet for their help in the
conduction of NOE experiments.
11. Agami, C.; Couty, F.; Evano, G. Tetrahedron: Asymme-
try 2002, 297–302.
12. Couty, F.; Prim, D. Tetrahedron: Asymmetry 2002, 13,
2619–2624.
References
1. Hesse, M. Ring Enlargements in Organic Chemistry;
VCH: Weinheim; New York; Basel; Cambridge, 1991.
2. For some recent examples see: (a) Papa, C.; Tomasini, C.
Eur. J. Org. Chem. 2000, 1569–1576; (b) Butler, D. C. D.;
Inman, G. A.; Alper, H. J. Org. Chem. 2000, 65, 5887–
5890; (c) Davoli, P.; Forni, A.; Moretti, I.; Prati, F.;
Torre, G. Tetrahedron 2001, 57, 1801–1812; (d) Friedolin,
W.; Eberbach, W. Tetrahedron 2001, 57, 4349–4358; (e)
Ducray, R.; Ciufolini, M. A. Angew. Chem., Int. Ed.
Engl. 2002, 41, 4688–4691.
3. (a) Cossy, J.; Dumas, C.; Gomez Pardo, D. Eur. J. Org.
Chem. 1999, 1693–1699; (b) Calvez, O.; Chiaroni, A.;
Langlois, N. Tetrahedron Lett. 1998, 39, 9447–9450.
4. (a) Cossy, J.; Mirguet, O.; Gomez Pardo, D.; Desmurs,
J.-R. Tetrahedron Lett. 2001, 42, 5705–5707; (b) Cossy,
13. Joucla, M.; Fouchet, B.; Hamelin, J. Tetrahedron 1985,
41, 2707–2715.
14. Selected data: Compound 27: H NMR (300 MHz): 3.01
1
(t, J=9.5 Hz, 1H, H5), 3.19 (d, J=13.1 Hz, 1H,
CHHPh), 3.26 (dd, J=9.5 and 3.3 Hz, 1H, H5%), 3.50
(ddd, J=3.3, 7.1, 9.5 Hz, 1H, H4), 3.73 (d, J=8.5 Hz,
1H, H2), 3.96 (d, J=13.1 Hz, 1H, CHHPh), 4.03 (dd,
J=7.1 and 8.4 Hz, 1H, H3), 7.21–7.48 (m, 13H, Ar), 7.63
(d, J=7.5 Hz, 2H, Ar). Compound 29: 1H NMR (300
MHz): 2.48 (t, J=9.8 Hz, 1H, H5), 3.21 (d, J=13.1 Hz,
1H, CHHPh), 3.50 (dd, J=9.5 and 7.5 Hz, 1H, H5%), 3.66
(ddd, J=6.5, 7.5, 9.5 Hz, 1H, H4), 4.01 (d, J=13.1 Hz,
1H, CHHPh), 4.07 (d, J=7.9 Hz, 1H, H2), 4.52 (dd,
J=6.5 and 7.9 Hz, 1H, H3), 7.21–7.60 (m, 15H, Ar).